1 / 8

Decreasing Sleep-Time Blood Pressure Reduces Cardiovascular Risk

This study investigates the impact of decreasing sleep-time blood pressure on cardiovascular risk. Results show that a progressive decrease in sleep-time blood pressure is the most significant predictor of event-free survival. Proper patient evaluation by ambulatory monitoring is necessary to target this novel therapeutic strategy.

clemmon
Download Presentation

Decreasing Sleep-Time Blood Pressure Reduces Cardiovascular Risk

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DECREASING SLEEP-TIME BLOOD PRESSURE DETERMINED BY AMBULATORY MONITORING REDUCES CARDIOVASCULAR RISK Ramón C. Hermida, PhD; Diana E. Ayala, MD, MPH, PhD; Artemio Mojón, PhD; José R. Fernández, PhD Bioengineering & Chronobiology Laboratories, University of Vigo, Campus Universitario, Vigo, 36310 Spain www.clinicaltrials.gov, NCT00295542

  2. Objectives • We investigated whether reduced cardiovascular risk is more related to the progressive decrease of asleep or awake blood pressure. J Am Coll Cardiol 2011;58:1165-1173

  3. Background • Independent studies have concluded that elevated sleep-time blood pressure is a better predictor of cardiovascular risk than the awake or 24h blood pressure means. • However, the impact on cardiovascular risk of changes in these ambulatory blood pressure characteristics has not been properly investigated. J Am Coll Cardiol 2011;58:1165-1173

  4. Methods • We prospective studied 3344 subjects (1718 men/1626 women), 52.6±14.5 years of age, during a median follow-up of 5.6 years. • Those with hypertension at baseline were randomized to ingest all their prescribed hypertension medications upon awakening or ≥1 of them at bedtime. • Blood pressure was measured for 48h at baseline, and again annually or more frequently (quarterly) if treatment adjustment was required. J Am Coll Cardiol 2011;58:1165-1173

  5. Results • Using data collected at baseline, when asleep blood pressure was adjusted by awake mean, only the former was a significant predictor of outcome in a Cox proportional-hazard model also adjusted for sex, age, and diabetes. • Analyses of changes in ambulatory blood pressure during follow-up revealed a 17% reduction in cardiovascular risk for each 5 mmHg decrease in asleep systolic blood pressure mean (P<0.001), independently of changes in any other ambulatory blood pressure parameter. J Am Coll Cardiol 2011;58:1165-1173

  6. HR as a function of the change in asleep SBP mean during follow-up HR was adjusted by age, sex, diabetes, baseline BP, and number of hypertension medications used for treatment. Studied population was divided into five classes of equal size (quintiles). Negative change indicates a BP reduction during follow-up. J Am Coll Cardiol 2011;58:1165-1173

  7. HR as a function of the change in clinic SBP during follow-up. HR was adjusted by age, sex, diabetes, baseline BP, and number of hypertension medications used for treatment. Studied population was divided into five classes of equal size (quintiles). Negative change indicates a BP reduction during follow-up. J Am Coll Cardiol 2011;58:1165-1173

  8. Conclusions • The sleep-time blood pressure mean is the most significant prognostic marker of cardiovascular morbidity and mortality. • Most important, the progressive decrease in asleep blood pressure, a novel therapeutic target that requires proper patient evaluation by ambulatory monitoring, was the most significant predictor of event-free survival. J Am Coll Cardiol 2011;58:1165-1173

More Related